{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:38:07Z","timestamp":1792679887902,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T00:00:00Z","timestamp":1358985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1038\/leu.2013.24","type":"journal-article","created":{"date-parts":[[2013,1,24]],"date-time":"2013-01-24T07:55:13Z","timestamp":1359014113000},"page":"1697-1706","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":101,"title":["Hypoxia-inducible factor (HIF)-1\u03b1 suppression in myeloma cells blocks tumoral growth in vivo inhibiting angiogenesis and bone destruction"],"prefix":"10.1038","volume":"27","author":[{"given":"P","family":"Storti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bolzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Donofrio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Airoldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Guasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Toscani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Martella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lazzaretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Agnelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Patrene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ma\u00efga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Colla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Neri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Amiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Aversa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"David Roodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,1,24]]},"reference":[{"key":"BFleu201324_CR1","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/j.beha.2007.08.002","volume":"20","author":"K Podar","year":"2007","unstructured":"Podar K, Richardson PG, Hideshima T, Chauhan D, Anderson KC . The malignant clone and the bone-marrow environment. Best Pract Res Clin Haematol 2007; 20: 597\u2013612.","journal-title":"Best Pract Res Clin Haematol"},{"key":"BFleu201324_CR2","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1182\/blood.V93.9.3064.409k07_3064_3073","volume":"93","author":"A Vacca","year":"1999","unstructured":"Vacca A, Ribatti D, Presta M, Minischetti M, Iurlaro M, Ria R et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood 1999; 93: 3064\u20133073.","journal-title":"Blood"},{"key":"BFleu201324_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/sj.leu.2404067","volume":"20","author":"A Vacca","year":"2006","unstructured":"Vacca A, Ribatti D . Bone marrow angiogenesis in multiple myeloma. Leukemia 2006; 20: 193\u2013199.","journal-title":"Leukemia"},{"key":"BFleu201324_CR4","first-page":"3111","volume":"6","author":"SV Rajkumar","year":"2000","unstructured":"Rajkumar SV, Leong T, Roche PC . Prognostic value of bone marrow angiogenesis in multiple myeloma. Clin Cancer Res 2000; 6: 3111\u20133116.","journal-title":"Clin Cancer Res"},{"key":"BFleu201324_CR5","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0093-7754(01)90025-9","volume":"28","author":"NC Munshi","year":"2001","unstructured":"Munshi NC, Wilson C . Increased bone marrow microvessel density in newly diagnosed multiple myeloma carries a poor prognosis. Semin Oncol 2001; 28: 565\u2013569.","journal-title":"Semin Oncol"},{"key":"BFleu201324_CR6","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1136\/jcp.2003.013110","volume":"57","author":"MG Alexandrakis","year":"2004","unstructured":"Alexandrakis MG, Passam FH, Dambaki C, Pappa CA, Stathopoulos EN . The relation between bone marrow angiogenesis and the proliferation index Ki-67 in multiple myeloma. J Clin Pathol 2004; 57: 856\u2013860.","journal-title":"J Clin Pathol"},{"key":"BFleu201324_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1365-2141.2010.08141.x","volume":"149","author":"S Yaccoby","year":"2010","unstructured":"Yaccoby S . Advances in the understanding of myeloma bone disease and tumour growth. Br J Haematol 2010; 149: 311\u2013321.","journal-title":"Br J Haematol"},{"key":"BFleu201324_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1007\/s00774-009-0154-7","volume":"28","author":"GD Roodman","year":"2010","unstructured":"Roodman GD . Targeting the bone microenvironment in multiple myeloma. J Bone Miner Metab 2010; 28: 244\u2013250.","journal-title":"J Bone Miner Metab"},{"key":"BFleu201324_CR9","doi-asserted-by":"crossref","first-page":"2630","DOI":"10.1182\/blood.V95.8.2630","volume":"95","author":"B Dankbar","year":"2000","unstructured":"Dankbar B, Padro T, Leo R, Feldmann B, Kropff M, Mesters RM et al. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma. Blood 2000; 95: 2630\u20132636.","journal-title":"Blood"},{"key":"BFleu201324_CR10","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1182\/blood-2004-07-2909","volume":"105","author":"K Podar","year":"2005","unstructured":"Podar K, Anderson KC . The pathophisiologic role of VEGF in hematologic malignancies: therapeutic implications. Blood 2005; 105: 1383\u20131395.","journal-title":"Blood"},{"key":"BFleu201324_CR11","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1182\/blood-2002-09-2907","volume":"101","author":"G Bisping","year":"2003","unstructured":"Bisping G, Leo R, Wenning D, Dankbar B, Padr\u00f3 T, Kropff M et al. Paracrine interactions of basic fibroblast growth factor and interleukin-6 in multiple myeloma. Blood 2003; 101: 2775\u20132783.","journal-title":"Blood"},{"key":"BFleu201324_CR12","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1182\/blood-2003-06-1883","volume":"102","author":"S Colla","year":"2003","unstructured":"Colla S, Morandi F, Lazzaretti M, Polistena P, Svaldi M, Coser P et al. Do human myeloma cells directly produce basic FGF? Blood 2003; 102: 3071\u20133072.","journal-title":"Blood"},{"key":"BFleu201324_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1182\/blood.V98.1.187","volume":"98","author":"VS Shapiro","year":"2001","unstructured":"Shapiro VS, Mollenauer MN, Weiss A . Endogenous CD28 expressed on myeloma cells up-regulates interleukin-8 production: implications for multiple myeloma progression. Blood 2001; 98: 187\u2013193.","journal-title":"Blood"},{"key":"BFleu201324_CR14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1182\/blood-2002-10-3257","volume":"102","author":"N Giuliani","year":"2003","unstructured":"Giuliani N, Colla S, Lazzaretti M, Sala R, Roti G, Mancini C et al. Pro-angiogenic properties of human myeloma cells: production of angiopoietin-1 and its potential relationship to myeloma-induced angiogenesis. Blood 2003; 102: 638\u2013645.","journal-title":"Blood"},{"key":"BFleu201324_CR15","doi-asserted-by":"publisher","first-page":"2166","DOI":"10.1038\/sj.leu.2403976","volume":"19","author":"S Colla","year":"2005","unstructured":"Colla S, Morandi F, Lazzaretti M, Rizzato R, Lunghi P, Bonomini S et al. Human myeloma cells express the bone regulating gene Runx2\/Cbfa1 and produce osteopontin that is involved in angiogenesis in multiple myeloma patients. Leukemia 2005; 19: 2166\u20132176.","journal-title":"Leukemia"},{"key":"BFleu201324_CR16","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1007\/s00109-007-0281-3","volume":"85","author":"MC Brahimi-Horn","year":"2007","unstructured":"Brahimi-Horn MC, Chiche J, Pouyss\u00e9gur J . Hypoxia and cancer. J Mol Med 2007; 85: 1301\u20131307.","journal-title":"J Mol Med"},{"key":"BFleu201324_CR17","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/cdd.2008.21","volume":"15","author":"EB Rankin","year":"2008","unstructured":"Rankin EB, Giaccia AJ . The role of hypoxia-inducible factors in tumorigenesis. Cell Death Differ 2008; 15: 678\u2013685.","journal-title":"Cell Death Differ"},{"key":"BFleu201324_CR18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s10555-007-9066-y","volume":"26","author":"D Liao","year":"2007","unstructured":"Liao D, Johnson RS . Hypoxia: a key regulator of angiogenesis in cancer. Cancer Metastasis Rev 2007; 26: 281\u2013290.","journal-title":"Cancer Metastasis Rev"},{"key":"BFleu201324_CR19","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/cdd.2008.12","volume":"15","author":"A Weidemann","year":"2008","unstructured":"Weidemann A, Johnson RS . Biology of HIF-1\u03b1. Cell Death Differ 2008; 15: 621\u2013627.","journal-title":"Cell Death Differ"},{"key":"BFleu201324_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/sj.cdd.4402315","volume":"15","author":"K Lisy","year":"2008","unstructured":"Lisy K, Peet DJ . Turn me on: regulating HIF transcriptional activity. Cell Death Differ 2008; 15: 642\u2013649.","journal-title":"Cell Death Differ"},{"key":"BFleu201324_CR21","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.tibs.2008.08.002","volume":"33","author":"M Yee Koh","year":"2008","unstructured":"Yee Koh M, Spivak-Kroizman TR, Powis G . HIF-1 regulation: not so easy come, easy go. Trends Biochem Sci 2008; 33: 526\u2013634.","journal-title":"Trends Biochem Sci"},{"key":"BFleu201324_CR22","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.semcancer.2008.11.009","volume":"19","author":"GL Semenza","year":"2009","unstructured":"Semenza GL . Regulation of cancer cell metabolism by hypoxia-inducible factor 1. Semin Cancer Biol 2009; 19: 12\u201316.","journal-title":"Semin Cancer Biol"},{"key":"BFleu201324_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.critrevonc.2005.12.003","volume":"59","author":"K Hirota","year":"2006","unstructured":"Hirota K, Semenza GL . ReguIation of angiogenesis by hypoxia-inducibIe factor 1. Crit Rev OncoI Hematol 2006; 59: 15\u201326.","journal-title":"Crit Rev OncoI Hematol"},{"key":"BFleu201324_CR24","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1002\/cbf.1660","volume":"28","author":"JC Utting","year":"2010","unstructured":"Utting JC, Flanagan AM, Brandao-Burch A, Orriss IR, Arnett TR . Hypoxia stimulates osteoclast formation from human peripheral blood. Cell Biochem Funct 2010; 28: 374\u2013380.","journal-title":"Cell Biochem Funct"},{"key":"BFleu201324_CR25","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature07019","volume":"454","author":"A Bozec","year":"2008","unstructured":"Bozec A, Bakiri L, Hoebertz A, Eferl R, Schilling AF, Komnenovic V et al. Osteoclast size is controlled by Fra-2 through LIF\/LIF-receptor signalling and hypoxia. Nature 2008; 454: 221\u2013225.","journal-title":"Nature"},{"key":"BFleu201324_CR26","doi-asserted-by":"publisher","first-page":"4157","DOI":"10.1158\/0008-5472.CAN-06-2355","volume":"67","author":"T Hiraga","year":"2007","unstructured":"Hiraga T, Kizaka-Kondoh S, Hirota K, Hiraoka M, Yoneda T . Hypoxia and hypoxia-inducible factor-1 expression enhance osteolytic bone metastases of breast cancer. Cancer Res 2007; 67: 4157\u20134163.","journal-title":"Cancer Res"},{"key":"BFleu201324_CR27","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1038\/leu.2010.193","volume":"24","author":"S Colla","year":"2010","unstructured":"Colla S, Storti P, Donofrio G, Todoerti K, Bolzoni M, Lazzaretti M et al. Low bone marrow oxygen tension and hypoxia-inducible factor-1\u03b1 overexpression characterize patients with multiple myeloma: role on the transcriptional and proangiogenic profiles of CD138(+) cells. Leukemia 2010; 24: 1967\u20131970.","journal-title":"Leukemia"},{"key":"BFleu201324_CR28","doi-asserted-by":"publisher","first-page":"5082","DOI":"10.1158\/0008-5472.CAN-08-4603","volume":"69","author":"J Zhang","year":"2009","unstructured":"Zhang J, Sattler M, Tonon G, Grabher C, Lababidi S, Zimmerhackl A et al. Targeting angiogenesis via a c-Myc\/hypoxia-inducible factor-1alpha-dependent pathway in multiple myeloma. Cancer Res 2009; 69: 5082\u20135090.","journal-title":"Cancer Res"},{"key":"BFleu201324_CR29","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1038\/leu.2011.122","volume":"25","author":"SK Martin","year":"2011","unstructured":"Martin SK, Diamond P, Gronthos S, Peet DJ, Zannettino AC . The emerging role of hypoxia, HIF-1 and HIF-2 in multiple myeloma. Leukemia 2011; 25: 1533\u20131542.","journal-title":"Leukemia"},{"key":"BFleu201324_CR30","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.1182\/blood-2011-09-380410","volume":"119","author":"AK Azab","year":"2012","unstructured":"Azab AK, Hu J, Quang P, Azab F, Pitsillides C, Awwad R et al. Hypoxia promotes dissemination of multiple myeloma through acquisition of epithelial to mesenchymal transition-like features. Blood 2012; 119: 5782\u20135794.","journal-title":"Blood"},{"key":"BFleu201324_CR31","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1182\/blood-2010-02-269126","volume":"116","author":"J Hu","year":"2010","unstructured":"Hu J, Handisides DR, Van Valckenborgh E, De Raeve H, Menu E, Vande Broek I et al. Targeting the multiple myeloma hypoxic niche with TH-302, a hypoxia-activated prodrug. Blood 2010; 116: 1524\u20131527.","journal-title":"Blood"},{"key":"BFleu201324_CR32","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/leu.2010.270","volume":"25","author":"P Storti","year":"2011","unstructured":"Storti P, Donofrio G, Colla S, Airoldi I, Bolzoni M, Agnelli L et al. HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients. Leukemia 2011; 25: 527\u2013537.","journal-title":"Leukemia"},{"key":"BFleu201324_CR33","first-page":"9","volume":"14","author":"RA Campbell","year":"2008","unstructured":"Campbell RA, Berenson JR . Animal models of multiple myeloma and their utility in drug discovery. Curr Protoc Pharmacol 2008; Chapter 14, Unit 14: 9.","journal-title":"Curr Protoc Pharmacol"},{"key":"BFleu201324_CR34","doi-asserted-by":"publisher","first-page":"6871","DOI":"10.1182\/blood-2011-04-346775","volume":"118","author":"S D'Souza","year":"2011","unstructured":"D'Souza S, del Prete D, Jin S, Sun Q, Huston AJ, Kostov FE et al. Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease. Blood 2011; 118: 6871\u20136880.","journal-title":"Blood"},{"key":"BFleu201324_CR35","first-page":"810","volume":"90","author":"K Asosingh","year":"2005","unstructured":"Asosingh K, De Raeve H, de Ridder M, Storme GA, Willems A, Van Riet I et al. Role of the hypoxic bone marrow microenvironment in 5T2MM murine myeloma tumor progression. Haematologica 2005; 90: 810\u2013817.","journal-title":"Haematologica"},{"key":"BFleu201324_CR36","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1158\/1535-7163.MCT-09-0150","volume":"8","author":"Y Hu","year":"2009","unstructured":"Hu Y, Kirito K, Yoshida K, Mitsumori T, Nakajima K, Nozaki Y et al. Inhibition of hypoxia-inducible factor-1 function enhances the sensitivity of multiple myeloma cells to melphalan. Mol Cancer Ther 2009; 8: 2329\u20132338.","journal-title":"Mol Cancer Ther"},{"key":"BFleu201324_CR37","doi-asserted-by":"publisher","first-page":"4470","DOI":"10.1182\/blood-2006-11-056747","volume":"109","author":"S Colla","year":"2007","unstructured":"Colla S, Zhan F, Xiong W, Wu X, Xu H, Stephens O et al. The oxidative stress response regulates DKK1 expression through the JNK signaling cascade in multiple myeloma plasma cells. Blood 2007; 109: 4470\u20134477.","journal-title":"Blood"},{"key":"BFleu201324_CR38","doi-asserted-by":"publisher","first-page":"2565","DOI":"10.1182\/blood-2006-06-032664","volume":"109","author":"L Veschini","year":"2007","unstructured":"Veschini L, Belloni D, Foglieni C, Cangi MG, Ferrarini M, Caligaris-Cappio F et al. Hypoxia-inducible transcription factor-1 alpha determines sensitivity of endothelial cells to the proteosome inhibitor bortezomib. Blood 2007; 109: 2565\u20132570.","journal-title":"Blood"},{"key":"BFleu201324_CR39","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1182\/blood-2007-02-074617","volume":"110","author":"S Colla","year":"2007","unstructured":"Colla S, Tagliaferri S, Morandi F, Lunghi P, Donofrio G, Martorana D et al. The new tumor-suppressor gene inhibitor of growth family member 4 (ING4) regulates the production of proangiogenic molecules by myeloma cells and suppresses hypoxia-inducible factor-1 alpha (HIF-1alpha) activity: involvement in myeloma-induced angiogenesis. Blood 2007; 110: 4464\u20134475.","journal-title":"Blood"},{"key":"BFleu201324_CR40","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/leu.2008.255","volume":"23","author":"HF Negaard","year":"2009","unstructured":"Negaard HF, Iversen N, Bowitz-Lothe IM, Sandset PM, Steinsvik B, Ostenstad B et al. Increased bone marrow microvascular density in haematological malignancies is associated with differential regulation of angiogenic factors. Leukemia 2009; 23: 162\u2013169.","journal-title":"Leukemia"},{"key":"BFleu201324_CR41","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1038\/sj.leu.2402714","volume":"16","author":"BK Arendt","year":"2002","unstructured":"Arendt BK, Velazquez-Dones A, Tschumper RC, Howell KG, Ansell SM, Witzig TE et al. Interleukin 6 induces monocyte chemoattractant protein-1 expression in myeloma cells. Leukemia 2002; 16: 2142\u20132147.","journal-title":"Leukemia"},{"key":"BFleu201324_CR42","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ijc.10642","volume":"101","author":"E Van Valckenborgh","year":"2002","unstructured":"Van Valckenborgh E, Bakkus M, Munaut C, No\u00ebl A, Pierre Y, Asosingh K et al. Upregulation of matrix metalloproteinase-9 in murine 5T33 multiple myeloma cells by interaction with bone marrow endothelial cells. Int J Cancer 2002; 101: 512\u2013518.","journal-title":"Int J Cancer"},{"key":"BFleu201324_CR43","doi-asserted-by":"publisher","first-page":"32628","DOI":"10.1074\/jbc.M806266200","volume":"283","author":"A Purushothaman","year":"2008","unstructured":"Purushothaman A, Chen L, Yang Y, Sanderson RD . Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma. J Biol Chem 2008; 283: 32628\u201332636.","journal-title":"J Biol Chem"},{"key":"BFleu201324_CR44","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1182\/blood.V96.2.671","volume":"96","author":"SJ Choi","year":"2000","unstructured":"Choi SJ, Cruz JC, Craig F, Chung H, Devlin RD, Roodman GD et al. Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma. Blood 2000; 96: 671\u2013675.","journal-title":"Blood"},{"key":"BFleu201324_CR45","doi-asserted-by":"publisher","first-page":"4615","DOI":"10.1182\/blood-2002-04-1121","volume":"100","author":"N Giuliani","year":"2002","unstructured":"Giuliani N, Colla S, Sala R, Moroni M, Lazzaretti M, La Monica S et al. Human myeloma cells stimulate the receptor activator of nuclear factor-kappa B ligand (RANKL) in T lymphocytes: a potential role in multiple myeloma bone disease. Blood 2002; 100: 4615\u20134621.","journal-title":"Blood"},{"key":"BFleu201324_CR46","first-page":"154","volume":"21","author":"KJ Hatfield","year":"2010","unstructured":"Hatfield KJ, Bedringsaas SL, Ryningen A, Gjertsen BT, Bruserud O . Hypoxia increases HIF-1\u03b1 expression and constitutive cytokine release by primary human acute myeloid leukaemia cells. Eur Cytokine Netw 2010; 21: 154\u2013164.","journal-title":"Eur Cytokine Netw"},{"key":"BFleu201324_CR47","doi-asserted-by":"publisher","first-page":"5405","DOI":"10.1182\/blood-2011-11-390849","volume":"119","author":"C Nishida","year":"2012","unstructured":"Nishida C, Kusubata K, Tashiro Y, Gritli I, Sato A, Ohki-Koizumi M et al. MT1-MMP plays a critical role in hematopoiesis by regulating HIF-mediated chemokine\/cytokine gene transcription within niche cells. Blood 2012; 119: 5405\u20135416.","journal-title":"Blood"},{"key":"BFleu201324_CR48","first-page":"1138","volume":"63","author":"B Krishnamachary","year":"2003","unstructured":"Krishnamachary B, Berg-Dixon S, Kelly B, Agani F, Feldser D, Ferreira G et al. Regulation of colon carcinoma cell invasion by hypoxia-inducible factor 1. Cancer Res 2003; 63: 1138\u20131143.","journal-title":"Cancer Res"},{"key":"BFleu201324_CR49","doi-asserted-by":"publisher","first-page":"7249","DOI":"10.1158\/0008-5472.CAN-04-4426","volume":"65","author":"L Li","year":"2005","unstructured":"Li L, Lin X, Staver M, Shoemaker A, Semizarov D, Fesik SW et al. Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo. Cancer Res 2005; 65: 7249\u20137258.","journal-title":"Cancer Res"},{"key":"BFleu201324_CR50","doi-asserted-by":"publisher","first-page":"3598","DOI":"10.1158\/1535-7163.MCT-08-0510","volume":"7","author":"LM Greenberger","year":"2008","unstructured":"Greenberger LM, Horak ID, Filpula D, Sapra P, Westergaard M, Frydenlund HF et al. A RNA antagonist of hypoxia-inducible factor-1alpha, EZN-2968, inhibits tumor cell growth. Mol Cancer Ther 2008; 7: 3598\u20133608.","journal-title":"Mol Cancer Ther"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201324","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201324.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:12:16Z","timestamp":1648739536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,24]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["BFleu201324"],"URL":"https:\/\/doi.org\/10.1038\/leu.2013.24","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,24]]},"assertion":[{"value":"5 December 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 January 2013","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2013","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}